Can we do without chemotherapy? A perspective on the combinations nivolumab-chemotherapy and nivolumab–ipilimumab in metastatic gastric and esophageal cancer

Detalles Bibliográficos
Autores principales: Derks, Sarah, van Laarhoven, Hanneke W. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9761794/
https://www.ncbi.nlm.nih.gov/pubmed/36544539
http://dx.doi.org/10.1177/17588359221142788
_version_ 1784852749466206208
author Derks, Sarah
van Laarhoven, Hanneke W. M.
author_facet Derks, Sarah
van Laarhoven, Hanneke W. M.
author_sort Derks, Sarah
collection PubMed
description
format Online
Article
Text
id pubmed-9761794
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-97617942022-12-20 Can we do without chemotherapy? A perspective on the combinations nivolumab-chemotherapy and nivolumab–ipilimumab in metastatic gastric and esophageal cancer Derks, Sarah van Laarhoven, Hanneke W. M. Ther Adv Med Oncol Editorial SAGE Publications 2022-12-17 /pmc/articles/PMC9761794/ /pubmed/36544539 http://dx.doi.org/10.1177/17588359221142788 Text en © The Author(s), 2022. https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Editorial
Derks, Sarah
van Laarhoven, Hanneke W. M.
Can we do without chemotherapy? A perspective on the combinations nivolumab-chemotherapy and nivolumab–ipilimumab in metastatic gastric and esophageal cancer
title Can we do without chemotherapy? A perspective on the combinations nivolumab-chemotherapy and nivolumab–ipilimumab in metastatic gastric and esophageal cancer
title_full Can we do without chemotherapy? A perspective on the combinations nivolumab-chemotherapy and nivolumab–ipilimumab in metastatic gastric and esophageal cancer
title_fullStr Can we do without chemotherapy? A perspective on the combinations nivolumab-chemotherapy and nivolumab–ipilimumab in metastatic gastric and esophageal cancer
title_full_unstemmed Can we do without chemotherapy? A perspective on the combinations nivolumab-chemotherapy and nivolumab–ipilimumab in metastatic gastric and esophageal cancer
title_short Can we do without chemotherapy? A perspective on the combinations nivolumab-chemotherapy and nivolumab–ipilimumab in metastatic gastric and esophageal cancer
title_sort can we do without chemotherapy? a perspective on the combinations nivolumab-chemotherapy and nivolumab–ipilimumab in metastatic gastric and esophageal cancer
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9761794/
https://www.ncbi.nlm.nih.gov/pubmed/36544539
http://dx.doi.org/10.1177/17588359221142788
work_keys_str_mv AT derkssarah canwedowithoutchemotherapyaperspectiveonthecombinationsnivolumabchemotherapyandnivolumabipilimumabinmetastaticgastricandesophagealcancer
AT vanlaarhovenhannekewm canwedowithoutchemotherapyaperspectiveonthecombinationsnivolumabchemotherapyandnivolumabipilimumabinmetastaticgastricandesophagealcancer

Ejemplares similares